Drug safety and efficacy due to premature release into the bloodstream and poor biodistribution remains a problem despite seminal advances in this area. To circumvent these limitations, we report drug cyclization based on dynamic covalent linkages to devise a dual lock for the small-molecule anticancer drug, camptothecin (CPT). Drug activity is "locked" within the cyclic structure by the redox responsive disulfide and pH-responsive boronic acid-salicylhydroxamate and turns on only in the presence of acidic pH, reactive oxygen species and glutathione through traceless release. Notably, the dual-responsive CPT is more active (100-fold) than the non-cleavable (permanently closed) analogue. We further include a bioorthogonal handle in the backbone for functionalization to generate cyclic-locked, cell-targeting peptide- and protein-CPTs, for targeted delivery of the drug and traceless release in triple negative metastatic breast cancer cells to inhibit cell growth at low nanomolar concentrations.

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.202314143DOI Listing

Publication Analysis

Top Keywords

traceless release
12
cancer cells
8
drug
6
macrocyclic dual-locked
4
dual-locked "turn-on"
4
"turn-on" drug
4
drug selective
4
selective traceless
4
release
4
release cancer
4

Similar Publications

Controllable surface modification of nanoparticulate drug delivery vectors is key to enhancing specific desirable properties such as colloidal stability, targeting, and stimuli-responsive cargo release. Metal-organic frameworks (MOFs) have been proposed as potential delivery devices, with surface modification achieved by various bioconjugate "click" reactions, including copper-catalysed and strain-promoted azide-alkyne cycloaddition. Herein, we show that photo-induced nitrile imine-mediated tetrazole-ene cycloaddition (NITEC) can be used to surface-modify tetrazole-appended Zr MOFs with maleimides, and vice versa, with the extent of this traceless surface functionalisation controlled by the length of photoirradiation.

View Article and Find Full Text PDF

Reaction-based fluorogenic sensing of lethal cyanide anions in aqueous matrices remains a big challenge. We have revisited the reported approach about an intramolecular crossed-benzoin reaction leading to the release of a phenol-based fluorophore. Fluorescence assays and RP-HPLC-MS analyses have helped us to highlight its limitations related to poor aqueous stability of probes and impossibility to achieve molecular amplification despite the assumed catalytic activation mechanism.

View Article and Find Full Text PDF

Light-Activated Gene Expression System Using a Caging-Group-Free Photoactivatable Dye.

Angew Chem Int Ed Engl

October 2024

Department of Applied Chemistry, Graduate School of Engineering, Osaka University, 2-1, Yamadaoka, Suita, Osaka, 5650871, Japan.

Optical regulation of transcription using chemical compounds is an effective strategy to manipulate gene expression spatiotemporally. Conventional caging approaches with photoremovable protecting groups may require intense UV-light exposure and release potentially toxic byproducts. To address these problems, here we developed a light-mediated transcriptional regulation system by combining a caging-group-free photoactivatable dye PaX and a multidrug-binding transcriptional regulator QacR.

View Article and Find Full Text PDF

As a traceless, bioreversible modification, the esterification of carboxyl groups in peptides and proteins has the potential to increase their clinical utility. An impediment is the lack of strategies to quantify esterase-catalyzed hydrolysis rates for esters in esterified biologics. We have developed a continuous Förster resonance energy transfer (FRET) assay for esterase activity based on a peptidic substrate and a protease, Glu-C, that cleaves a glutamyl peptide bond only if the glutamyl side chain is a free acid.

View Article and Find Full Text PDF

Efficient Capture and Traceless Release of Functional CD8 T Cells with a Microfluidic Chip for Enhanced and CD4-CAR Transduction.

Anal Chem

September 2024

Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200092, China.

Article Synopsis
  • Researchers developed a microfluidic chip that effectively purifies CD8 T cells using an optimized CD8 aptamer (A3t-MU), achieving a purity of 98.1%, which is significantly better than traditional methods.
  • This chip allows for the efficient isolation of CD8 T cells from various blood sources, facilitating the production of CAR T cells targeting CD4 expressed cells for leukemia treatment.
  • The resulting CD4-CAR transduced CD8 T cells demonstrated strong anti-cancer activity and tumor growth inhibition across several leukemia cell lines, highlighting the chip's potential in enhancing adoptive cell therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!